My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 748 / https://doi.org/10.3332/ecancer.2017.748

Research

Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma

Papillary thyroid carcinoma (PTC) is the most common thyroid cancer with multiple risk factors including exposure to ionising radiation. Oestrogens contribute to papillary carcinoma development by promoting cell proliferation and invasion of mutated epithelial follicular cells. The present study aimed to assess ER-α and PR expression in PTC and to correlate their expression with the clinicopathological parameters in this cancer. This study included 62 primary and six metastatic papillary thyroid carcinoma cases. Nineteen and 38.7% of primary PTC cases showed positive nuclear expression for ER and PR, respectively. Metastatic cases showed 66.7% positive ER expression and all were negative for PR. Oestrogen receptor expression showed significant higher positivity in metastatic compared to primary PTC (p = 0.02) and it was significantly associated with primary PTC associated with thyroiditis (p = .002). Progesterone receptor expression was significantly associated with old age in primary PTC (p = .003) and it showed significant coparallel expression with ER (p = .000). Oestrogen and progesterone receptors expressed in papillary thyroid carcinoma opening the door for further studies to verify if those patients could benefit from hormonal therapy. Oestrogen receptor seems to have a role in metastatic process of PTC as malignant cells express it in metastatic more than primary site. The presence of lymphocytes in the stroma may promote ER expression in adjacent PTC, necessitating further studies on PTC cases associated with Hashimoto thyroiditis to verify this assumed relationship.

Keywords: papillary thyroid carcinoma, ER, PR, immunohistochemistry

Categories:

Head & neck

Loading Article Metrics ... Please wait

Related articles

Case Report: Metastasizing pleomorphic adenoma of the parotid gland

Abstract | Full Article | PDF Published: 15 Aug 2017 / https://doi.org/10.3332/ecancer.2017.758

Research: Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica National Children’s Hospital Oncology Unit from January 2009 to December 2015

Abstract | Full Article | PDF Published: 24 Jul 2017 / https://doi.org/10.3332/ecancer.2017.754

Case Report: Soft-tissue sarcomas in the head and neck: 25 years of experience

Abstract | Full Article | PDF | Spanish Published: 02 Jun 2017 / https://doi.org/10.3332/ecancer.2017.740

Conference Report: Conference report on the Indo Global Summit on Head and Neck Oncology (IGSHNO 2017-BMCON-IV), 24–26 February 2017, Jaipur, India

Abstract | Full Article | PDF Published: 31 May 2017 / https://doi.org/10.3332/ecancer.2017.739

Case Report: Volumetric arc therapy for total scalp irradiation: case report for a recurrent basal cell carcinoma of the scalp

Abstract | Full Article | PDF Published: 11 May 2017 / https://doi.org/10.3332/ecancer.2017.737



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence